Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Severe dyspnoea with alteration of the diffusion capacity of the lung associated with fingolimod treatment.
Restoring immune tolerance in neuromyelitis optica: Part I.
Complement is activated in progressive multiple sclerosis cortical grey matter lesions.
Drinking away fatigue in multiple sclerosis.
Normonatremic osmotic demyelination in the setting of acquired immune deficiency syndrome and malnutrition: case report and literature review.
Refractory trigeminal neuralgia responsive to nabiximols in a patient with multiple sclerosis.
Toll-like receptor (TLR)7 and TLR9 agonists enhance interferon (IFN) beta-1a's immunoregulatory effects on B cells in patients with relapsing-remitting multiple sclerosis (RRMS).
Radiologically isolated syndrome: An update on a rare entity.
Is Season of Birth Important for Multiple Sclerosis Risk?
Inhaled Sargramostim Induces Resolution of Pulmonary Alveolar Proteinosis in Lysinuric Protein Intolerance.
Fampridine and quality of life in individuals with multiple sclerosis.
Utilization of Dimethyl Fumarate and Related Molecules for Treatment of Multiple Sclerosis, Cancer, and Other Diseases.
Functional Promoter Polymorphisms of MMP-2 C-735T and MMP-9 C-1562T and Their Synergism with MMP-7 A-181G in Multiple Sclerosis.
[Cell depletion and myoablation for neuroimmunological diseases].
Therapy of Vestibular Paroxysmia, Superior Oblique Myokymia, and Ocular Neuromyotonia.
Integrated multidisciplinary clinics should be the gold standard in managing progressive MS - YES.
Ubiquitination of RORγt at Lysine 446 Limits Th17 Differentiation by Controlling Coactivator Recruitment.
The Transition to Secondary Progressive Multiple Sclerosis: An Exploratory Qualitative Study of Health Professionals' Experiences.
Three cases of neuromyelitis optica spectrum disorder.
Longitudinal Study of Retinal Nerve Fiber Layer Thickness and Macular Volume in Patients With Neuromyelitis Optica Spectrum Disorder.
HLA-DRB*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosis.
Haemopoietic stem-cell transplantation for multiple sclerosis: what next?
Pediatric Demyelination.
Changing EDSS Progression in Placebo Cohorts in Relapsing MS: A Systematic Review and Meta-Regression.
Perspectives on Safety and Efficacy-The BOLD Phase 2 Extension Study of Siponimod in Relapsing-Remitting Multiple Sclerosis.

Pages